🇺🇸 FDA
Patent

US 9617228

Oligomer-containing substituted aromatic triazine compounds

granted A61KA61K31/53A61K47/60

Quick answer

US patent 9617228 (Oligomer-containing substituted aromatic triazine compounds) held by Nektar Therapeutics expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/53, A61K47/60, A61P, A61P25/04